The increasing prevalence of older adults with diabetes has become a major social burden.
Diabetes, frailty, and cognitive dysfunction are closely related to the mechanisms of aging …

Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of antidiabetic drugs
that improve the glycaemia via several molecular pathways. Recent evidence suggest that …

Background Diabetic encephalopathy is manifested by cognitive dysfunction. Salidroside, a
nature compound isolated from Rhodiola rosea L, has the effects of anti-inflammatory and …

Potential association between oral levofloxacin use and hypoglycemic emergency (HE)
have been established. However, a large epidemiological study is required to verify this …

There is an increasing number of patients worldwide with sleep disturbances and diabetes.
Various sleep disorders, including long or short sleep duration and poor sleep quality of …

Background The fear of hypoglycemia in type 2 diabetes mellitus (T2DM) patients with
hypoglycemia has seriously affected their quality of life. They are always afraid of …

Diabetes mellitus (DM) is a common metabolic disorder that affects multiple organ systems.
DM also affects brain processes, contributing to various CNS disorders, including …

Background: Diabetes is a risk factor for cognitive impairment, and disease duration is
associated with geriatric decline and functional disabilities. Objective: This study aimed to …

Background The prevalence of type 2 diabetes (DM) has been increasing globally,
particularly among older adults who are more susceptible to DM-related complications …

Background Hypoglycemia is the most common complication in the treatment of diabetes
mellitus. Accumulating evidence indicated that severe hypoglycemia could induce cognitive …